Immunohistochemical peculiarities of cell adhesion molecules distribution in benign and malignant brain meningiomas

Authors

  • W. E. Voteva
  • S. I. Tertishniy

DOI:

https://doi.org/10.14739/2310-1237.2014.3.37028

Keywords:

Meningioma, Cell Adhesion, E-cadherin, β-catenin

Abstract

Aim. Meningiomas are widespread neoplasms of the brain, constituting 24-30% of all primary intracranial tumors. In order to determine the expression level of cell adhesion molecules β-catenin and E-cadherin in 20 specimens of brain with the help of immunohistochemical methods the expression of these molecules in benign and malignant meningiomas was investigated.

Methods and results. The correlation relationship between the expression level of β-catenin and E-cadherin in malignant and benign meningiomas was determined. It is shown that the expression level of β-catenin in the different subtypes of benign meningiomas differs and, conversely, they have a similar expression level of E-cadherin.

Conclusion. Most of benign meningiomas are characterized by significantly higher expression levels of cell adhesion molecules than anaplastic ones.

References

Louis, D.N., Ohgaki, H., Wiestler, O.D., &Cavenee, W.K. (Eds.). (2007). World Health Organization Classification of Tumours of the Central Nervous System.IARC, Lyon.

Nagaishi, M., Nobusawa, S., Tanaka, Y., Ikota, H., Yokoo, H., &Nakazato, Y. (2012). Slug, Twist, and E-Cadherin as immunohistochemical biomarkers in meningeal tumors.PLoS One, 7(9), doi: 10.1371/journal.pone.0046053.

Zhou, K., Wang, G., Wang, Y., Jin, H., Yang, S., & Liu, C. (2010).The potential involvement of E-cadherin and beta-catenins in meningioma. PLoS One,5(6), doi: 10.1371/journal.pone.0011231.

Pecina-Slaus, N.,Cicvara-Pecina, T., &Kafka, A. (2012). Epithelial-to-mesenchymal transition: possible role in meningiomas. Frontiers in bioscience (Elite edition), 1(4), 889–896.

Curtis, M.W., Johnson, K.R., &Wheelock, M.J. (2008). E-cadherin/catenin complexes are formed cotranslationally in the endoplasmic reticulum/Golgi compartments. Cell communication & adhesion, 15(4), 365–378.doi: 10.1080/15419060802460748.

van Roy, F., &Berx, G. (2008).The cell-cell adhesion molecule E-cadherin.Cellular and molecular life sciences: CMLS, 65(23), 3756–3788.doi: 10.1007/s00018-008-8281-1.

Stemmler, M. P. (2008). Cadherins in development and cancer.MolecularbioSystems, 4(8), 835–850.doi: 10.1039/b719215k.

Motta, F.J., Valera, E.T., Lucio-Eterovic, A.K., Queiroz, R. G., Neder, L., Scrideli, C. A., et al. (2008). Differential expression of E-cadherin gene in human neuroepithelial tumors.Genetics and molecular research: GMR, 7(2), 295–304.

Ellison, D.W., Onilude, O.E., Lindsey, J.C., Lusher, M. E., Weston, C. L., Taylor, R. E., et al. (2005). Вeta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 23(31), 7951–7957.

Brunner, E.C., Romeike, B.F., Jung, M., Comtesse, N., & Meese, E. (2006). Altered expression of beta-catenin/E-cadherin in meningiomas.Histopathology, 49(2), 178–187.

How to Cite

1.
Voteva WE, Tertishniy SI. Immunohistochemical peculiarities of cell adhesion molecules distribution in benign and malignant brain meningiomas. Pathologia [Internet]. 2014Dec.23 [cited 2024May8];(3). Available from: http://pat.zsmu.edu.ua/article/view/37028

Issue

Section

Original research